PTC Therapeutics Raises FY2026 Sales Guidance from $1.180B-$1.280B to $1.290B-$1.320B vs $1.262B Est
Benzinga Newsdesk 3 days ago
NewsGuidance
PTC Therapeutics (NASDAQ:PTCT) raises FY2026 sales outlook from $1.180 billion-$1.280 billion to $1.290 billion-$1.320 billion vs $1.262 billion estimate.
PTC Therapeutics (NASDAQ:PTCT) raises FY2026 sales outlook from $1.180 billion-$1.280 billion to $1.290 billion-$1.320 billion vs $1.262 billion estimate.